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Liver fibrosis staging provides prognostic value, although hampered by observer
variability. We used digital analysis to develop diagnostic morphometric scores for
significant fibrosis, cirrhosis and fibrosis staging in chronic hepatitis C.
Materials and Methods:
We automated the measurement of 44 classical and new morphometric descriptors.
The reference was histological METAVIR fibrosis (F) staging (F0 to F4) on liver
biopsies. The derivation population included 416 patients and liver biopsies ≥20
mm-length. Two validation population included 438 patients.
Results:
In the derivation population, the area under the receiver operating characteristic
(AUROC) for clinically significant fibrosis (F stage ≥2) of a logistic score combining
5 new descriptors (stellar fibrosis area, edge linearity, bridge thickness, bridge
number, nodularity) was 0.957. The AUROC for cirrhosis of 6 new descriptors (edge
linearity, nodularity, portal stellar fibrosis area, portal distance, granularity,
fragmentation) was 0.994. Predicted METAVIR F staging combining 8
morphometric descriptors agreed well with METAVIR F staging by pathologists: k =
0.868. Morphometric score of clinically significant fibrosis had a higher correlation
with porto-septal fibrosis area (rs = 0.835) than METAVIR F staging (rs = 0.756, P <
0.001) and the same correlations with fibrosis biomarkers, e.g., serum hyaluronate:
rs = 0.484 versus rs = 0.476 for METAVIR F (P = 0.862). In the validation
population, the AUROCs of clinically significant fibrosis and cirrhosis scores were,
respectively: 0.893 and 0.993 in 153 patients (biopsy < 20 mm); 0.955 and 0.994 in
285 patients (biopsy ≥ 20 mm). The three morphometric diagnoses agreed with
consensus expert reference as well as or better than diagnoses by first-line
pathologists in 285 patients, respectively: significant fibrosis: 0.733 versus 0.733
(k), cirrhosis: 0.900 versus 0.827, METAVIR F: 0.881 versus 0.865.
Conclusion:
The new automated morphometric scores provide reproducible and accurate
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